Inventors:
JEFFREY W. TYNER - PORTLAND OR, US
BRIAN J. DRUKER - PORTLAND OR, US
MARC LORIAUX - PORTLAND OR, US
MARY V. LUTTROPP - GRESHAM OR, US
International Classification:
C40B 30/06
Abstract:
Methods for screening cells obtained from a subject for aberrant kinase activity are disclosed. The methods include placing cells isolated from the subject in contact with a set of siRNAs, wherein each individual siRNA is at an addressable location on the array and specifically inhibits expression of a tyrosine kinase. The siRNA is introduced into the blood cells or bone marrow cells by electroporation. After introduction of the siRNA, the cells are then assayed for proliferation and/or viability as compared to a control. A decreased proliferation and/or viability of the cells as compared to a control identifies a siRNA that inhibits the proliferation and/or viability of the cells, thus identifying the tyrosine kinase having aberrant tyrosine kinase activity in the subject.